{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:38:53Z","timestamp":1648967933751},"reference-count":21,"publisher":"American Society of Consultant Pharmacists","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.4140\/tcp.n.2010.374","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T02:16:48Z","timestamp":1294885008000},"page":"374-378","source":"Crossref","is-referenced-by-count":1,"title":["Review of Isolated Systolic Hypertension in Older Adults"],"prefix":"10.4140","volume":"25","author":[{"given":"Neetha","family":"Kamath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Cappuzzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Rosamund W, Flegal K, Friday G et al. Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2007;115:69-171.","DOI":"10.1161\/CIRCULATIONAHA.106.179918"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Duprez DA. Systolic hypertension in the elderly: addressing an unmet need. Am J Med 2008;121:179-84.","DOI":"10.1016\/j.amjmed.2007.10.027"},{"key":"3","unstructured":"World Health Report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002. Available at <a target=\"_blank\" href='http:\/\/www.who.int\/whr\/2002\/en\/whr02_en.pdf'>http:\/\/www.who.int\/whr\/2002\/en\/whr02_en.pdf<\/a>"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"5","unstructured":"Saseen JJ, Maclaughlin EJ. In DiPiro JT, Talbert RL, Yee GC et al., eds. Pharmacotherapy: A Pathophysiologic Approach. 7th ed. New York, NY: McGraw-Hill; 2008:139-71."},{"key":"6","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.06-2490","article-title":"Hypertensive crisis: challenges and management","volume":"131","author":"PE Marik","year":"2007","journal-title":"Chest"},{"key":"7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.HYP.37.3.869","article-title":"Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III","volume":"37","author":"SS Franklin","year":"2001","journal-title":"Hypertension"},{"key":"8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.292.9.1074","article-title":"Systolic hypertension in older persons","volume":"292","author":"SI Chaudhry","year":"2004","journal-title":"JAMA"},{"key":"9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002512-200118050-00005","article-title":"Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension","volume":"18","author":"J Wang","year":"2001","journal-title":"Drugs Aging"},{"key":"10","doi-asserted-by":"crossref","unstructured":"SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"JA Staessen","year":"1997","journal-title":"Lancet"},{"key":"12","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","article-title":"for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension","volume":"16","author":"L Liu","year":"1990","journal-title":"J Hypertens"},{"key":"13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","article-title":"Should beta-blockers remain first choice in the treatment of primary hypertension? A metaanalysis","volume":"366","author":"LH Lindholm","year":"2005","journal-title":"Lancet"},{"key":"14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6904-7-4","article-title":"Does atenolol differ from otheradrenergic blockers?","volume":"7","author":"I Aursnes","year":"2007","journal-title":"BMC Clin Pharmacol"},{"key":"15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMoa010273","article-title":"Characteristics of patients with uncontrolled hypertension in the United States","volume":"345","author":"DJ Hyman","year":"2001","journal-title":"N Engl J Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.HYP.16.6.617","article-title":"\"White coat\" versus \"sustained\" borderline hypertension in Tecumseh, Michigan","volume":"16","author":"S Julius","year":"1990","journal-title":"Hypertension"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Pickering T, for the American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory BP monitoring. Am J Hypertens 1996;9:1-11.","DOI":"10.1016\/0895-7061(95)00341-X"},{"key":"18","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1592\/phco.20.17.1384.34891","article-title":"Effect of pharmacist intervention and initiation of home BP monitoring in patients with uncontrolled hypertension","volume":"20","author":"BM Mehos","year":"2000","journal-title":"Pharmacotherapy"},{"key":"19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diaspect.20.4.239","article-title":"Considerations for the pharmacological treatment of diabetes in older adults","volume":"20","author":"PS Odegard","year":"2007","journal-title":"Diabetes Spectr"},{"key":"20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/diacare.15.1.75","article-title":"Benefits and risks with glyburide and glipizide in elderly NIDDM patients","volume":"15","author":"RG. Brodows","year":"1992","journal-title":"Diabetes Care"},{"key":"21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"KA Fox","year":"2004","journal-title":"Circulation"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:07:14Z","timestamp":1559938034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2010\/00000025\/00000006\/art00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6,1]]}},"alternative-id":["47578204644M2566"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2010.374","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}